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tors focus on providing the pharmaceutical industry with a
mechanism for assessing reward for innovation. They also assess
the pattern of new listings and changes in the structure of expen-
ditures under the Australian Pharmaceutical Beneﬁts Scheme.
The study shows that the average time from marketing approval
to reimbursement is 15 months, that expenditure by government
is driven mostly by volume increase for products that have been
listed for more than 12 months and not by recent listings or price
changes, and that products are more likely to be rejected if they
are assessed on a cost-effectiveness basis (42% approved) than
on a cost-minimisation basis (88% approved). CONCLUSIONS:
This is part of an ongoing effort to develop key performance
indicators and to date has been supported by industry and 
Government. In part, this is a response to the improved levels of
transparency and cooperation engendered by the Free Trade
Agreement between Australia and the USA.
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OBJECTIVES: To explore the relationship between the length of
a General Practitioner consultation and the number of prescrip-
tions issued. Initially it is necessary to establish if any trends exist
in prescriber activity and consultation length. METHODS: The
DIN-LINK database was used to obtain data on prescriber activ-
ity. DIN-LINK is a longitudinal patient database comprising over
3.8 million electronic patient records and is populated with data
from General Practices across Great Britain. This analysis was
based on patients consulting with a GP in the year to August
2004. Data on the number of prescriptions issued in a consulta-
tion in the database were stratiﬁed by consultation length, with
1–3 minutes being the lowest consultation length band, and
21–24 minutes the highest band. A 13–15 minute band was
included as it constituted the central value of this stratiﬁcation.
The unpaired student t-test was used to test for statistical sig-
niﬁcance between groups. RESULTS: The cohort for this analy-
sis comprised 467,446 patients, of whom 45% were male. The
mean age of the cohort was 42.4 years. Over the one-year period,
the cohort had 2,425,790 consultations, during which 2,181,974
prescriptions were issued. Statistically signiﬁcant differences in
the mean number of prescriptions per consultation were found
between the lowest and central band, and the lowest and highest
band (p < 0.001). At a consultation length of 1–3 minutes, 
GPs prescribed an average of 0.6 prescriptions per consultation.
This value peaked and plateaued at 1.1 prescriptions per con-
sultation at a consultation length of 13–15 minutes. CONCLU-
SIONS: Prescribing increased as consultation length increased up
to 13–15 minutes, after which a plateau in prescriber activity
was seen. This suggests that the incremental beneﬁt of consulta-
tions over 15 minutes may be limited. Further study is planned
with quantiﬁcation of the relationship between consultation
length and prescriber activity. Regression analysis is planned for
2005.
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OBJECTIVES: To assess trends in prescriber activity related to
patient smoking status and ACORN socio-economic status. The
ﬁndings will be used to identify variables for subsequent regres-
sion analysis of the relationship between prescriber activity and
consultation length. METHODS: The DIN-LINK database was
used to obtain detailed data on prescriber activity. DIN-LINK is
a longitudinal patient database comprising over 3.8 million elec-
tronic patient records, populated with data from General Prac-
tices across Great Britain. This analysis was based on patients
consulting with a GP in the year to August 2004. Patients were
stratiﬁed by smoking status and by ACORN socio-economic
classiﬁcation (CACI Ltd., www.caci.co.uk/acorn); measures of
prescriber activity were examined, including the number of pre-
scriptions per patient/per consultation, and the number of 
consultations per patient. The unpaired student t-test was used
to test for statistical signiﬁcant differences between groups.
RESULTS: The cohort comprised 467,446 patients, of which
339,275 had a record of smoking status and 415,418 had their
ACORN socio-economic status recorded. Among the sub-group
with smoking status recorded, signiﬁcant differences were found
between current smokers, non-smokers, and ex-smokers in mean
consultations per patient, prescriptions per patient, and pre-
scriptions per consultation. Although signiﬁcant results were
found, no trends were apparent. The only non-signiﬁcant com-
parisons were in mean prescriptions per consultation between
current smokers and ex-smokers, and in mean consultations 
per patient between current smokers and non-smokers. When
considering patients’ socio-economic status, those in the lowest
group (“Hard Pressed”) consulted more frequently and were
issued signiﬁcantly more prescriptions per head and signiﬁcantly
more prescriptions per consultation compared to the highest
ACORN group (“Wealthy Achievers”). CONCLUSIONS: We
found statistically signiﬁcant differences in prescriber activity
with respect to patients’ recorded smoking and socio-economic
status. Our ﬁndings have highlighted the potential of these two
factors as suitable variables for regression analysis planned for
2005.
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OBJECTIVE: The decision to prescribe one drug instead of
another within the same therapeutic class may be inﬂuenced by
a variety of drug-related, direct, or indirect factors; but little is
known about which considerations are most important in such
choices. The low-molecular-weight heparins (LMWHs) represent
a class of drugs that are commonly used and for which thera-
peutic equivalence has been debated in the literature. The
purpose of this study was to identify and compare factors per-
ceived by physicians and clinical pharmacists to be inﬂuential in
prescribing decisions among LMWHs. METHODS: Physicians
and clinical pharmacists were interviewed to elicit information
and rank factors that inﬂuence the prescribing and use of
LMWHs in community hospitals. For each factor, the mean and
median of the rating was determined along with the frequency
distribution across ratings. The nonparametric Mann-Whitney U
test was used to examine differences between physicians and clin-
ical pharmacists. RESULTS: Both groups considered efﬁcacy,
formulary status, and policies restricting drug use to be highly
inﬂuential in the decision to use one LMWH versus another.
Compared to clinical pharmacists, physicians rated personal
